Cordasco Financial Network’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-83
Closed -$5K 571
2021
Q4
$5K Hold
83
﹤0.01% 461
2021
Q3
$7K Buy
+83
New +$8.33K ﹤0.01% 429
2020
Q4
Sell
-83
Closed -$12K 534
2020
Q3
$12K Hold
83
0.01% 296
2020
Q2
$27K Sell
83
-1
-1% -$161 0.02% 204
2020
Q1
$8K Buy
84
+1
+1% +$62 0.01% 278
2019
Q4
$3K Hold
83
﹤0.01% 398
2019
Q3
$2K Hold
83
﹤0.01% 437
2019
Q2
$3K Hold
83
﹤0.01% 408
2019
Q1
$4K Buy
83
+41
+98% +$2.07K ﹤0.01% 382
2018
Q4
$2K Hold
42
﹤0.01% 357
2018
Q3
$3K Hold
42
﹤0.01% 320
2018
Q2
$2K Hold
42
﹤0.01% 356
2018
Q1
$2K Hold
42
﹤0.01% 246
2017
Q4
$2K Hold
42
﹤0.01% 230
2017
Q3
$3K Hold
42
﹤0.01% 214
2017
Q2
$4K Hold
42
﹤0.01% 201
2017
Q1
$3K Buy
+42
New +$3.35K ﹤0.01% 218

Other funds holding INO

Cordasco Financial Network's INO Position: Q1 2022 in Review

Cordasco Financial Network sold out of Inovio Pharmaceuticals (INO) in Q1 2022, closing a stake of 83 shares — an estimated $5K sold.

Cordasco Financial Network first reported a position in INO in Q1 2017 and held it in 17 quarters. The position peaked at $27K in Q2 2020. 198 funds tracked by Wall St. Rank hold INO as of Q1 2022.

  • Cordasco Financial Network reported no remaining Inovio Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Cordasco Financial Network sold 83 Inovio Pharmaceuticals shares in Q1 2022, an estimated $5K.
  • Cordasco Financial Network first reported a position in Inovio Pharmaceuticals in Q1 2017 and held it in 17 quarters.
  • Cordasco Financial Network's Inovio Pharmaceuticals position peaked at $27K in Q2 2020.
  • 198 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2022.

Based on Cordasco Financial Network's 13F filing for Q1 2022, filed 21 Apr 2022.